0000897069-15-000026.txt : 20150128 0000897069-15-000026.hdr.sgml : 20150128 20150128095227 ACCESSION NUMBER: 0000897069-15-000026 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150128 DATE AS OF CHANGE: 20150128 EFFECTIVENESS DATE: 20150128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aragen Bioscience, Inc. CENTRAL INDEX KEY: 0001594773 IRS NUMBER: 810655676 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-210871 FILM NUMBER: 15553417 BUSINESS ADDRESS: STREET 1: 380 WOODVIEW AVENUE CITY: MORGAN HILL STATE: CA ZIP: 95037 BUSINESS PHONE: (408) 779-1700, #13 MAIL ADDRESS: STREET 1: 380 WOODVIEW AVENUE CITY: MORGAN HILL STATE: CA ZIP: 95037 D/A 1 primary_doc.xml X0707 D/A LIVE 0001594773 Aragen Bioscience, Inc. 380 WOODVIEW AVENUE MORGAN HILL CA CALIFORNIA 95037 (408) 779-1700, #13 CALIFORNIA None None Corporation true William R. Srigley 380 Woodview Avenue Morgan Hill CA CALIFORNIA 95037 Executive Officer Director Christian C. Simonsen 380 Woodview Avenue Morgan Hill CA CALIFORNIA 95037 Executive Officer Manmahesh Kantipudi c/o Aragen Bioscience, Inc. 380 Woodview Avenue Morgan Hill CA CALIFORNIA 95037 Director J.B. Gupta c/o Aragen Bioscience, Inc. 380 Woodview Avenue Morgan Hill CA CALIFORNIA 95037 Director Biotechnology Decline to Disclose 06b true 0000897069-14-000020 2014-01-10 true true true The offering is being made in connection with the acquisiton of the Company, which will close in three separate tranches. 0 3734515 2719193 1015322 Common Stock to be issued in three tranches and Series B Preferred Stock to be issued in tranche 1. false 1 0 0 0 false Aragen Bioscience, Inc. William R. Srigley William R. Srigley President and Chief Executive Officer 2015-01-27